CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...